$XON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PRECIGEN, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PRECIGEN, INC.. Get notifications about new insider transactions in PRECIGEN, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 7.15 | 226,256 | 1,618,138 | 24,099,654 | 24.3 M to 24.1 M (-0.93 %) |
| Jun 09 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.97 | 203,233 | 1,416,717 | 24,325,910 | 24.5 M to 24.3 M (-0.83 %) |
| Jun 07 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.66 | 76,685 | 510,408 | 24,529,143 | 24.6 M to 24.5 M (-0.31 %) |
| Jun 07 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.59 | 83,992 | 553,801 | 24,605,828 | 24.7 M to 24.6 M (-0.34 %) |
| May 20 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.50 | 121,500 | 789,629 | 25,755,592 | 25.9 M to 25.8 M (-0.47 %) |
| May 20 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.85 | 134,043 | 918,570 | 25,877,092 | 26 M to 25.9 M (-0.52 %) |
| May 14 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Option Exercise | M | 0.00 | 97,276 | 0 | 0 | |
| May 14 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Sell | S | 6.40 | 47,433 | 303,571 | 705,057 | 752.5 K to 705.1 K (-6.30 %) |
| May 14 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Buy | M | 0.00 | 97,276 | 0 | 752,490 | 655.2 K to 752.5 K (+14.85 %) |
| May 14 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.52 | 122,389 | 798,184 | 26,275,850 | 26.4 M to 26.3 M (-0.46 %) |
| May 14 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 7.00 | 150,000 | 1,050,510 | 26,398,239 | 26.5 M to 26.4 M (-0.57 %) |
| May 12 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.40 | 151,164 | 966,936 | 26,548,239 | 26.7 M to 26.5 M (-0.57 %) |
| May 12 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.34 | 114,603 | 726,743 | 26,699,403 | 26.8 M to 26.7 M (-0.43 %) |
| May 10 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.55 | 150,000 | 982,485 | 26,814,006 | 27 M to 26.8 M (-0.56 %) |
| May 10 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.54 | 100,000 | 653,850 | 26,964,006 | 27.1 M to 27 M (-0.37 %) |
| May 06 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 6.86 | 57,261 | 392,639 | 27,064,006 | 27.1 M to 27.1 M (-0.21 %) |
| May 06 2021 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Sell | S | 7.08 | 94,950 | 672,237 | 27,121,267 | 27.2 M to 27.1 M (-0.35 %) |
| May 06 2021 | XON | PRECIGEN, INC. | Osborne D. Bradford | VP, Finance and Acc ... | Option Exercise | A | 8.17 | 30,000 | 245,100 | 30,000 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Option Exercise | A | 0.00 | 22,697 | 0 | 22,697 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Option Exercise | A | 0.00 | 97,276 | 0 | 97,276 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Option Exercise | A | 0.00 | 26,102 | 0 | 26,102 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Turley James S | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Turley James S | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Turley James S | Director | Grant | A | 7.71 | 8,106 | 62,497 | 159,904 | 151.8 K to 159.9 K (+5.34 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | SHAPIRO ROBERT B | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | SHAPIRO ROBERT B | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | SHAPIRO ROBERT B | Director | Grant | A | 7.71 | 8,171 | 62,998 | 193,911 | 185.7 K to 193.9 K (+4.40 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Grant | A | 7.71 | 7,328 | 56,499 | 177,926 | 170.6 K to 177.9 K (+4.30 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | KINDLER JEFFREY B | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | KINDLER JEFFREY B | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | KINDLER JEFFREY B | Director | Grant | A | 7.71 | 8,949 | 68,997 | 214,209 | 205.3 K to 214.2 K (+4.36 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | Hassan Fred | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Hassan Fred | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Hassan Fred | Director | Grant | A | 7.71 | 7,328 | 56,499 | 154,687 | 147.4 K to 154.7 K (+4.97 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | Gupta Vinita D | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Gupta Vinita D | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Gupta Vinita D | Director | Grant | A | 7.71 | 7,328 | 56,499 | 147,820 | 140.5 K to 147.8 K (+5.22 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Grant | A | 7.71 | 6,485 | 49,999 | 337,205 | 330.7 K to 337.2 K (+1.96 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Grant | A | 7.71 | 8,106 | 62,497 | 257,396 | 249.3 K to 257.4 K (+3.25 %) |
| Mar 29 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Option Exercise | A | 0.00 | 32,425 | 0 | 32,425 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Option Exercise | A | 5.65 | 44,214 | 249,809 | 44,214 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Grant | A | 7.71 | 12,970 | 99,999 | 18,329,996 | 18.3 M to 18.3 M (+0.07 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Buy | M | 0.00 | 62,189 | 0 | 249,290 | 187.1 K to 249.3 K (+33.24 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Buy | M | 0.00 | 62,189 | 0 | 330,720 | 268.5 K to 330.7 K (+23.16 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | Gupta Vinita D | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | Gupta Vinita D | Director | Buy | M | 0.00 | 62,189 | 0 | 140,492 | 78.3 K to 140.5 K (+79.42 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 0.00 | 62,189 | 0 | 170,598 | 108.4 K to 170.6 K (+57.37 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | SHAPIRO ROBERT B | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | SHAPIRO ROBERT B | Director | Buy | M | 0.00 | 62,189 | 0 | 185,740 | 123.6 K to 185.7 K (+50.33 %) |
| Mar 16 2021 | XON | PRECIGEN, INC. | Turley James S | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
| Mar 16 2021 | XON | PRECIGEN, INC. | Turley James S | Director | Buy | M | 0.00 | 62,189 | 0 | 151,798 | 89.6 K to 151.8 K (+69.40 %) |
| Mar 05 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Option Exercise | M | 5.69 | 2,968 | 16,888 | 0 | |
| Mar 05 2021 | XON | PRECIGEN, INC. | ALVAREZ CESAR L | Director | Buy | M | 5.69 | 2,968 | 16,888 | 187,101 | 184.1 K to 187.1 K (+1.61 %) |
| Mar 05 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Option Exercise | M | 5.69 | 2,968 | 16,888 | 0 | |
| Mar 05 2021 | XON | PRECIGEN, INC. | Frank Steven | Director | Buy | M | 5.69 | 2,968 | 16,888 | 268,531 | 265.6 K to 268.5 K (+1.12 %) |
| Mar 05 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 5.69 | 2,968 | 16,888 | 0 | |
| Mar 05 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 5.69 | 2,968 | 16,888 | 108,409 | 105.4 K to 108.4 K (+2.81 %) |
| Jan 07 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Option Exercise | M | 0.00 | 500,000 | 0 | 0 | |
| Jan 07 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Sell | S | 8.92 | 260,045 | 2,318,535 | 655,214 | 915.3 K to 655.2 K (-28.41 %) |
| Jan 07 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Buy | M | 0.00 | 500,000 | 0 | 915,259 | 415.3 K to 915.3 K (+120.41 %) |
| Jan 06 2021 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Option Exercise | M | 0.00 | 18,940 | 0 | 37,878 | |
| Jan 06 2021 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Sell | S | 10.56 | 6,096 | 64,404 | 340,020 | 346.1 K to 340 K (-1.76 %) |
| Jan 06 2021 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Buy | M | 0.00 | 18,940 | 0 | 346,116 | 327.2 K to 346.1 K (+5.79 %) |
| Jan 06 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Option Exercise | M | 0.00 | 17,667 | 0 | 35,332 | |
| Jan 06 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Sell | S | 10.56 | 9,040 | 95,507 | 415,259 | 424.3 K to 415.3 K (-2.13 %) |
| Jan 06 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Buy | M | 0.00 | 17,667 | 0 | 424,299 | 406.6 K to 424.3 K (+4.34 %) |
| Jan 06 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Option Exercise | M | 0.00 | 18,940 | 0 | 37,878 | |
| Jan 06 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Sell | S | 10.56 | 9,677 | 102,237 | 274,652 | 284.3 K to 274.7 K (-3.40 %) |
| Jan 06 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Buy | M | 0.00 | 18,940 | 0 | 284,329 | 265.4 K to 284.3 K (+7.14 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Option Exercise | M | 0.00 | 9,766 | 0 | 9,765 | |
| Jan 05 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Sell | S | 10.16 | 5,271 | 53,553 | 265,389 | 270.7 K to 265.4 K (-1.95 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Buy | M | 0.00 | 9,766 | 0 | 270,660 | 260.9 K to 270.7 K (+3.74 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Option Exercise | M | 0.00 | 9,766 | 0 | 9,765 | |
| Jan 05 2021 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Sell | S | 10.16 | 4,951 | 50,302 | 269,930 | 274.9 K to 269.9 K (-1.80 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Buy | M | 0.00 | 9,766 | 0 | 274,881 | 265.1 K to 274.9 K (+3.68 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Option Exercise | M | 0.00 | 9,766 | 0 | 9,765 | |
| Jan 05 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Sell | S | 10.16 | 5,279 | 53,635 | 406,632 | 411.9 K to 406.6 K (-1.28 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Sabzevari Helen | President and CEO | Buy | M | 0.00 | 9,766 | 0 | 411,911 | 402.1 K to 411.9 K (+2.43 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Option Exercise | M | 0.00 | 9,766 | 0 | 9,765 | |
| Jan 05 2021 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Sell | S | 10.16 | 3,487 | 35,428 | 327,176 | 330.7 K to 327.2 K (-1.05 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Buy | M | 0.00 | 9,766 | 0 | 330,663 | 320.9 K to 330.7 K (+3.04 %) |
| Jan 05 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Option Exercise | M | 0.00 | 3,444 | 0 | 6,887 | |
| Jan 05 2021 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | M | 0.00 | 3,444 | 0 | 18,317,026 | 18.3 M to 18.3 M (+0.02 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Buy | J | 0.00 | 6,268 | 0 | 265,115 | 258.8 K to 265.1 K (+2.42 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 8,100 | 0 | 1,260,538 | 1.3 M to 1.3 M (+0.65 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 691,929 | 0 | 691,929 | 0 to 691.9 K |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 16,200 | 0 | 2,976,063 | 3 M to 3 M (+0.55 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,383,857 | 0 | 2,959,863 | 1.6 M to 3 M (+87.81 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,383,858 | 0 | 1,383,858 | 0 to 1.4 M |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 16,200 | 0 | 1,592,206 | 1.6 M to 1.6 M (+1.03 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,620 | 0 | 444,007 | 442.4 K to 444 K (+0.37 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 222,264 | 0 | 442,387 | 220.1 K to 442.4 K (+100.97 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 8,100 | 0 | 1,589,531 | 1.6 M to 1.6 M (+0.51 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 10,125 | 0 | 1,572,208 | 1.6 M to 1.6 M (+0.65 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,835 | 0 | 561,872 | 559 K to 561.9 K (+0.51 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 123,476 | 0 | 559,037 | 435.6 K to 559 K (+28.35 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,835 | 0 | 473,231 | 470.4 K to 473.2 K (+0.60 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,835 | 0 | 474,194 | 471.4 K to 474.2 K (+0.60 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,025 | 0 | 338,154 | 336.1 K to 338.2 K (+0.60 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 123,476 | 0 | 336,129 | 212.7 K to 336.1 K (+58.06 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 20,250 | 0 | 3,782,354 | 3.8 M to 3.8 M (+0.54 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,234,757 | 0 | 3,762,104 | 2.5 M to 3.8 M (+48.86 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 20,250 | 0 | 3,541,315 | 3.5 M to 3.5 M (+0.58 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 1,234,757 | 0 | 3,521,065 | 2.3 M to 3.5 M (+54.01 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 113,716 | 0 | 18,313,582 | 18.2 M to 18.3 M (+0.62 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Buy | J | 0.00 | 4,682,816 | 0 | 18,199,866 | 13.5 M to 18.2 M (+34.64 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Sell | J | 0.00 | 243,001 | 0 | 0 | 243 K to 0 (-100.00 %) |
| Dec 21 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Director | Sell | J | 0.00 | 13,340,645 | 0 | 0 | 13.3 M to 0 (-100.00 %) |
| Dec 17 2020 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Dec 17 2020 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Sell | S | 7.20 | 9,416 | 67,795 | 320,897 | 330.3 K to 320.9 K (-2.85 %) |
| Dec 17 2020 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Buy | M | 0.00 | 25,000 | 0 | 330,313 | 305.3 K to 330.3 K (+8.19 %) |
| Dec 17 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Dec 17 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Sell | S | 7.20 | 9,382 | 67,550 | 258,847 | 268.2 K to 258.8 K (-3.50 %) |
| Dec 17 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Buy | M | 0.00 | 25,000 | 0 | 268,229 | 243.2 K to 268.2 K (+10.28 %) |
| Dec 17 2020 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Dec 17 2020 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Sell | S | 7.20 | 12,190 | 87,768 | 260,894 | 273.1 K to 260.9 K (-4.46 %) |
| Dec 17 2020 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Buy | M | 0.00 | 25,000 | 0 | 273,084 | 248.1 K to 273.1 K (+10.08 %) |
| Oct 09 2020 | XON | PRECIGEN, INC. | Ares Trading S.A. | 10% Owner | Buy | P | 3.70 | 6,758,400 | 24,999,997 | 27,398,519 | 20.6 M to 27.4 M (+32.74 %) |
| Sep 28 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Option Exercise | A | 0.00 | 53,571 | 0 | 53,571 | |
| Sep 28 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Option Exercise | A | 3.50 | 74,656 | 261,296 | 74,656 | |
| Sep 28 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Grant | A | 3.50 | 21,428 | 74,998 | 13,517,050 | 13.5 M to 13.5 M (+0.16 %) |
| Sep 17 2020 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 17 2020 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Sell | S | 5.22 | 7,660 | 39,985 | 305,313 | 313 K to 305.3 K (-2.45 %) |
| Sep 17 2020 | XON | PRECIGEN, INC. | Sterling Rick L. | Chief Financial Off ... | Buy | M | 0.00 | 25,000 | 0 | 312,973 | 288 K to 313 K (+8.68 %) |
| Sep 17 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 17 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Sell | S | 5.22 | 7,660 | 39,985 | 243,229 | 250.9 K to 243.2 K (-3.05 %) |
| Sep 17 2020 | XON | PRECIGEN, INC. | Perez Jeffrey Thomas | SVP, IP Affairs | Buy | M | 0.00 | 25,000 | 0 | 250,889 | 225.9 K to 250.9 K (+11.07 %) |
| Sep 17 2020 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 17 2020 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Sell | S | 5.22 | 8,474 | 44,234 | 248,084 | 256.6 K to 248.1 K (-3.30 %) |
| Sep 17 2020 | XON | PRECIGEN, INC. | Lehr Donald P. | Chief Legal Officer | Buy | M | 0.00 | 25,000 | 0 | 256,558 | 231.6 K to 256.6 K (+10.80 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 1,664 | 7,089 | 220,123 | 218.5 K to 220.1 K (+0.76 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 3,355 | 15,098 | 218,459 | 215.1 K to 218.5 K (+1.56 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 1,993 | 8,490 | 212,653 | 210.7 K to 212.7 K (+0.95 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 4,018 | 18,081 | 210,660 | 206.6 K to 210.7 K (+1.94 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 10,779 | 45,919 | 435,561 | 424.8 K to 435.6 K (+2.54 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 21,741 | 97,835 | 424,782 | 403 K to 424.8 K (+5.39 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 8,952 | 38,136 | 1,562,083 | 1.6 M to 1.6 M (+0.58 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 18,054 | 81,243 | 1,553,131 | 1.5 M to 1.6 M (+1.18 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 30,514 | 129,990 | 2,527,347 | 2.5 M to 2.5 M (+1.22 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.50 | 61,544 | 276,948 | 2,496,833 | 2.4 M to 2.5 M (+2.53 %) |
| Aug 13 2020 | XON | PRECIGEN, INC. | KIRK RANDAL J | Executive Chairman | Buy | P | 4.26 | 10,792 | 45,974 | 470,396 | 459.6 K to 470.4 K (+2.35 %) |